Line of Credit and Long-Term Debt	12 Months Ended
Sep. 30, 2011
Line of Credit and Long-Term Debt [Abstract]
Line of Credit and Long-Term Debt	13. Line of Credit and Long-Term Debt In June 2006, in conjunction with the asset purchase agreement with Coloplast, the Company entered into an unsecured loan note deed with Coloplast with an outstanding principal amount of $5,340,000. The promissory note was non-interest bearing, payable and due in five equal installments of $1,068,000 payable annually on June 2. The Company discounted the note at 6.90%. The final payment of $1,068,000 was paid in May 2011. In December 2010, the Company entered into a credit facility with RBC Wealth Management. The credit facility consists of a revolving line of credit of up to $25,000,000 with interest accruing monthly at a variable rate of 1.375% at September 30, 2011. In conjunction with the closing of the Laprolan acquisition, on April 7, 2011, the Company drew down $15,057,775 from the line of credit. As of September 30, 2011, the Company had an outstanding balance under the revolving line of credit of $17,862,185.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References+ Details